Circulating tumour DNA dynamics predict recurrence in stage III melanoma patients receiving neoadjuvant immunotherapyWei Yen Chan, Helen Rizos, Ashleigh Stewart et al.|Journal of Experimental & Clinical Cancer Research|2024Cited by 22
Use of early circulating tumour DNA dynamics in patients with stage III melanoma receiving neoadjuvant combination immunotherapy.Wei Yen Chan, Helen Rizos, Alexander M. Menzies et al.|Journal of Clinical Oncology|2024Cited by 2
Abstract B044: Fragmentomic features of cell-free DNA predict late-stage melanoma treatment benefit and survivalAaron B. Beasley, Elin S. Gray, Alexander M. Menzies et al.|Clinical Cancer Research|2024Cited by 0
Abstract 731: Integrating ctDNA and FDG-PET dynamics to predict pathological response following neoadjuvant systemic therapy in stage III melanomaWei Yen Chan, Helen Rizos, Li Zhou et al.|Cancer Research|2025Cited by 0
Pre-Amplification of Cell-Free DNA: Balancing Amplification Errors with Enhanced SensitivityWei Yen Chan, Helen Rizos, Russell J. Diefenbach et al.|Biomolecules|2025Cited by 0